Last CNY48.72 CNY
Change Today -0.17 / -0.35%
Volume 79.5K
000513 On Other Exchanges
Symbol
Exchange
Shenzhen
Hong Kong
Frankfurt
As of 9:59 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by LIVZON PHARMACEUTICAL GROU-A (000513) in the last 6 months

Announced 05/15/14
200.00M for Livzon Mabpharm, Inc.
Private Placement

Livzon Mabpharm, Inc. announced that it has received CNY 200,000,000 in funding on May 15, 2014. The transaction included participation from existing investors Livzon Pharmaceutical Group Inc. and Joincare Pharmaceutical Group Industry Co.,Ltd. who invested CNY 102,000,000 and CNY 98,000,000 in their respective shareholding proportion of 51% and 49%. Pursuant to the transaction, registered capital of the company increased from CNY 300,000,000 to CNY 500,000,000. The ...
Read More


000513's price was unchanged after the transaction was announced on 05/15/14.
Investor / Buyer
Joincare Pharmaceutical Group Industry Co.,Ltd.
Livzon Pharmaceutical Group Inc.
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000513:CH CNY48.72 CNY -0.17

000513 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000513.
View Industry Companies
 

Industry Analysis

000513

Industry Average

Valuation 000513 Industry Range
Price/Earnings 30.1x
Price/Sales 3.1x
Price/Book 4.2x
Price/Cash Flow 18.6x
TEV/Sales 1.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIVZON PHARMACEUTICAL GROU-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.